Novo Integrated Sciences Inc. (NASDAQ:NVOS) shares traded 35.81% higher at $0.29 on Wall Street last session.
NVOS stock price is now 121.11% away from the 50-day moving average and 97.02% away from the 200-day moving average. The market capitalization of the company currently stands at $41.93M.
A total of 8.90% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NVOS stock. A new stake in Novo Integrated Sciences Inc. shares was purchased by VANGUARD GROUP INC during the first quarter worth $70,000. UBS GROUP AG invested $40,000 in shares of NVOS during the first quarter. In the first quarter, CUBIST SYSTEMATIC STRATEGIES, LLC acquired a new stake in Novo Integrated Sciences Inc. valued at approximately $38,000. In total, there are 15 active investors with 1.40% ownership of the company’s stock.
Novo Integrated Sciences Inc. (NASDAQ: NVOS) opened at $0.2370 on Tuesday. During the past 12 months, Novo Integrated Sciences Inc. has had a low of $0.07 and a high of $1.60. As of last week, the company has a debt-to-equity ratio of 0.09, a current ratio of 0.60, and a quick ratio of 0.50. The fifty day moving average price for NVOS is $0.1349 and a two-hundred day moving average price translates $0.1485 for the stock.
The latest earnings results from Novo Integrated Sciences Inc. (NASDAQ: NVOS) was released for May, 2023. The company reported revenue of $3.29 million for the quarter, compared to $13.85 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -76.23 percent.
Novo Integrated Sciences Inc.(NVOS) Company Profile
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates corporate-owned clinics. The company is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.
